Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Equity Average (2022 - 2025)

Neuraxis' Equity Average history spans 4 years, with the latest figure at $3.3 million for Q3 2025.

  • For Q3 2025, Equity Average rose 192.71% year-over-year to $3.3 million; the TTM value through Sep 2025 reached $3.3 million, up 192.71%, while the annual FY2024 figure was $332253.5, 109.52% up from the prior year.
  • Equity Average for Q3 2025 was $3.3 million at Neuraxis, up from $2.3 million in the prior quarter.
  • Across five years, Equity Average topped out at $3.3 million in Q3 2025 and bottomed at -$8.9 million in Q2 2023.
  • The 4-year median for Equity Average is -$3.5 million (2024), against an average of -$2.7 million.
  • The largest annual shift saw Equity Average fell 22.05% in 2023 before it soared 192.71% in 2025.
  • A 4-year view of Equity Average shows it stood at -$5.6 million in 2022, then soared by 77.87% to -$1.2 million in 2023, then soared by 111.11% to $136908.0 in 2024, then surged by 2287.82% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Equity Average are $3.3 million (Q3 2025), $2.3 million (Q2 2025), and $1.2 million (Q1 2025).